The signaling system that involves receptor activation of nuclear factor-κB (RANK) by its ligand (RANKL), which is regulated by the soluble decoy receptor osteoprotegerin (OPG), plays a role in the RANKL/RANK/OPG pathway of gene control of fetal development of bones and osteoporosis. This evidence concerns the gene TNFRSF11A and osteoporosis.